Skip to main content
Premium Trial:

Request an Annual Quote

Progenity: Surbhi Sarna

Progenity has appointed Surbhi Sarna to its board of directors effective July 1. She is currently a visiting partner at Y Combinator. Sarna founded nVision Medical and acted as CEO of the medical device company until it was acquired by Boston Scientific in 2018, where she led commercial efforts for nVision until 2020. She previously served in healthcare engineering roles at BioCardia and Abbott Vascular.

Sarna is a board member at medical device company Penumbra and on its audit and nominating and corporate governance committees. She's also on the board of trustees at Astia, which provides access to capital and networks to women entrepreneurs. 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.